ArticleThe journal of liquid biopsy2026
The potential survival gain and cost-effectiveness of circulating tumor DNA-guided treatment switching in advanced non-small cell lung cancer: A simulation modeling study.
Jeroen P Jansen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.